MRP ₹1406
(Inclusive of all Taxes)
₹210.9 Cashback (15%)
Provide Delivery Location
About Bonrange-PTH Pen 3 ml
Bonrange-PTH Pen 3 ml belongs to the class of medication called 'anabolic (promoting bone formation) agent' indicated for prevention and treatment of osteoporosis in adults and helps to strengthen the bone. This medicine also helps to reduce the risk of spine and hip fractures. Osteoporosis is a medical condition in which bone becomes thin or weak. The chance of developing osteoporosis increases with age, after menopause or by taking corticosteroid medications (such as prednisone) for a long period. If proper treatment is not provided then it can even result in broken bones.
Bonrange-PTH Pen 3 ml contains Teriparatide a synthetic form of the human parathyroid hormone, which helps to regulate calcium metabolism. Bonrange-PTH Pen 3 ml works by causing the body to build new bone by increasing bone strength and bone mass density (BMD) (thickness) and reduce the risk of fractures by stimulating bone formation. It also increases the thickness of bone and rebuilds bones which reduces the risk of spine and hip fractures.
Bonrange-PTH Pen 3 ml will be administered by a healthcare professional; do not self-administer. In some cases, Bonrange-PTH Pen 3 ml can cause side effects like nausea, vomiting, joint pain, leg cramps, swelling/redness at the injection site, upset stomach, diarrhea, constipation, runny nose, cough, and throat irritation. Most of these side effects of Bonrange-PTH Pen 3 ml do not require medical attention and gradually resolve over time. However, if these side effects persist longer, please consult your doctor.
To treat your condition effectually, continue taking Bonrange-PTH Pen 3 ml for as long as your doctor has prescribed. Consult your doctor before taking Bonrange-PTH Pen 3 ml if you are pregnant or breastfeeding; your doctor will prescribe you Bonrange-PTH Pen 3 ml only if the benefits outweigh the risks. Bonrange-PTH Pen 3 ml is not recommended for children below 18 years of age. Tell your doctor that you are taking Bonrange-PTH Pen 3 ml before you have any lab test as this medicine could interfere with the results. Bonrange-PTH Pen 3 ml may cause dizziness, lightheadedness, and fainting when you get up too quickly from a lying position. To avoid this problem, get out of bed slowly, resting your feet on the floor for a few minutes before standing up. Inform your doctor about your health condition and medications before taking Bonrange-PTH Pen 3 ml to rule out any side effects. Bonrange-PTH Pen 3 ml is a cold chain medicine, and so it has to be stored in the refrigerator between 2-8 degrees Celsius else its efficiency might be lost. Do not store in the freezer or the fridge.
Uses of Bonrange-PTH Pen 3 ml
Bonrange-PTH Pen 3 ml is used in the treatment of Osteoporosis, Postmenopausal osteoporosis. The detailed uses of Bonrange-PTH Pen 3 ml are as follows:

Have a query?
Directions for Use
Medicinal Benefits
Bonrange-PTH Pen 3 ml is a synthetic form of a natural human hormone called parathyroid hormone (PTH) that is prescribed to prevent and treat osteoporosis in persons with weak bones. It prevents the loss of bones that happens after menopause and helps to rebuild bones. Bonrange-PTH Pen 3 ml contains Teriparatide which works by causing the body to build new bone and by increasing bone strength and bone mass density (BMD) (thickness) and reduce the risk of fractures by stimulating bone formation. It also increases the thickness of bone and rebuilds bones which reduces the risk of spine and hip fractures. Bonrange-PTH Pen 3 ml is also indicated for the treatment of increasing bone mass in people with osteoporosis, glucocorticoid-induced osteoporosis.
How Bonrange-PTH Pen 3 ml Works
Storage
What if I have taken an overdose of Bonrange-PTH Pen 3 ml
Drug Warnings
Bonrange-PTH Pen 3 ml is not recommended if you have hypercalcemia (high calcium levels) or an overactive parathyroid gland, metastatic calcification (extra deposits of calcium in the body) and malabsorption syndrome (difficulty absorbing nutrition from food), kidney stones, kidney problems (moderate renal impairment), Paget’s disease of bone (abnormal bone changes), history of skeletal malignancies. It is important that your doctor check your progress regularly to make sure that Bonrange-PTH Pen 3 ml is working properly. Blood and urine tests may be needed to check for unwanted effects. Bonrange-PTH Pen 3 ml can increase the amount of calcium in your blood or urine. Talk to your doctor before or while using Bonrange-PTH Pen 3 ml if you have continuing nausea, vomiting, constipation, low energy or muscle weakness. These may be signs there is too much calcium in your blood. Consult your doctor before taking Bonrange-PTH Pen 3 ml if you are pregnant or breastfeeding; your doctor will prescribe you Bonrange-PTH Pen 3 ml only if the benefits outweigh the risks. Bonrange-PTH Pen 3 ml should not be given to children as safety and efficacy have not been established. Do not take Bonrange-PTH Pen 3 ml for longer durations unless prescribed by your doctor. If your condition does not improve even after taking the Bonrange-PTH Pen 3 ml full course, please consult your doctor. Bonrange-PTH Pen 3 ml may increase the risk of having cancer while taking longer durations. Talk to your doctor if you have concerns about this risk. Avoid consuming alcohol along with Bonrange-PTH Pen 3 ml as it could lead to increased drowsiness. Inform your doctor about your health condition and medications before taking Bonrange-PTH Pen 3 ml to rule out any side effects.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
RXLg Life Sciences India Pvt Ltd
₹66
(₹59.4 per unit)
RXCorona Remedies Pvt Ltd
₹1340.5
(₹393.2/ 1ml)
RXIntas Pharmaceuticals Ltd
₹5671.5
(₹1550.2/ 1ml)
Alcohol
Unsafe
You are recommended to avoid alcohol consumption while taking Bonrange-PTH Pen 3 ml. Alcohol intake, along with Bonrange-PTH Pen 3 ml, may cause increased drowsiness.
Pregnancy
Caution
It is advised not to take Bonrange-PTH Pen 3 ml if you are pregnant unless prescribed by the doctor as Bonrange-PTH Pen 3 ml is a pregnancy category C drug. Your doctor will prescribe Bonrange-PTH Pen 3 ml only if the benefits outweigh the risks.
Breast Feeding
Caution
It isn’t known if Bonrange-PTH Pen 3 ml passes into breast milk. If it does, it may cause side effects in a child who is breastfed. Talk to your doctor if you breastfeed your child.
Driving
Caution
It may cause dizziness, fatigue and blurring of vision; do not drive or operate heavy machinery if you feel drowsy.
Liver
Caution
Dose adjustment may be needed. Bonrange-PTH Pen 3 ml should be used with caution in patients with liver impairment/liver disease. Please consult your doctor if you have a liver impairment or any concerns regarding this.
Kidney
Caution
Tell your doctor if you have kidney disorders as after checking the health condition, a doctor will decide that this medicine is safe to prescribe or not.
Children
Caution
Bonrange-PTH Pen 3 ml should not be given to children or adolescents whose age is less than 18 years. Safety and effectiveness have not been established.
Heart
Consult your doctor
Please inform your doctor if you have a history of heart disease before using Bonrange-PTH Pen 3 ml. Your doctor will prescribe it only if the benefits outweigh the risks.
Geriatrics
Consult your doctor
Limited information available for use of Bonrange-PTH Pen 3 ml in elderly patients. Please consult your doctor.
Bonrange-PTH Pen 3 ml is used to treat osteoporosis (weak and brittle bones).
Bonrange-PTH Pen 3 ml contains Teriparatide is a synthetic form of a natural human hormone called parathyroid hormone (PTH). It works by increasing the number and activity of bone-forming cells (osteoblasts). This strengthens the bones and minimizes the risk of fractures.
Bonrange-PTH Pen 3 ml can cause kidney stones due to excess calcium deposition when used for a prolonged period. Please consult your doctor before taking Bonrange-PTH Pen 3 ml as a daily supplement if you have any kidney problems or a history of kidney stones.
Persons whose age is more than 35 years have low estrogen levels, female reaching menopause, too much consumption of alcohol, tobacco, or caffeine, use of glucocorticoid and lack of calcium and vitamin D in the foods are some of the factors that can increase the risk of osteoporosis.
Bonrange-PTH Pen 3 ml is a part of a complete program that includes modifications in diet, regular exercise, bone mineral density testing and intake of calcium and vitamin supplements. Follow all the guidelines given by the doctor very closely.
Yes, Bonrange-PTH Pen 3 ml may increase serum calcium, urinary calcium, and serum uric acid. Inform the person doing the tests that you are taking Bonrange-PTH Pen 3 ml.
You are not recommended to stop taking Bonrange-PTH Pen 3 ml without consulting your doctor, as stopping early might affect the treatment's effectiveness. Always follow your doctor’s instructions.
Osteoporosis is a condition that causes bones to become thin and weak. The risk of developing it grows with age, after menopause, or from long-term use of corticosteroid medications like prednisone.
Bonrange-PTH Pen 3 ml is not a steroid, it belongs to a class of medications called anabolic (promoting bone formation) agent.
You are advised to take Bonrange-PTH Pen 3 ml for as long as prescribed by a doctor to treat your condition effectively. Prolonged or long-term use of Bonrange-PTH Pen 3 ml increases the risk of cancer. Therefore, follow your doctor’s instructions and do not self-medicate.
Store Bonrange-PTH Pen 3 ml in a sterile, airtight tamper-proof container at a temperature of 2°C -8°C. Do not freeze.
Bonrange-PTH Pen 3 ml is not advised to use in some patients dealing with hyperparathyroidism, malignancy (cancer), metabolic bone disorder, or orthostatic hypotension (low blood pressure when standing up from sitting or lying down), renal impairment, urolithiasis (stone formation in the bladder or urinary tract). However, please consult a doctor if you have any concerns.
You are recommended to inform your doctor about any other medications, or supplements, you are using before starting Bonrange-PTH Pen 3 ml. This ensures potential interactions or side effects are avoided. Always follow your doctor’s guidance when combining treatments.
Bonrange-PTH Pen 3 ml is not recommended during pregnancy unless advised by a doctor, as there is no sufficient data on its safety for the mother or baby. If pregnancy is detected, consult your doctor immediately to evaluate the risks and discontinue use if necessary.
Bonrange-PTH Pen 3 ml has side effects such as nausea, joint pain, vomiting, leg cramps, swelling, upset stomach, diarrhoea, constipation, running nose, cough, and throat infection. These are temporary and do not require any medical treatment as they gradually reduce over time. Please, consult a doctor if these side effects persist.
Avoid using Bonrange-PTH Pen 3 ml if you have conditions like hypercalcemia, kidney stones, or Paget’s disease (abnormal bone growth). Regular blood and urine tests are essential to monitor calcium levels. Avoid use during pregnancy, breastfeeding, or in children unless advised by a physician. Alcohol should be avoided to prevent excessive drowsiness. Always inform your doctor your medical history and medications you are taking.
Country of origin
Manufacturer/Marketer address
Keep Refrigerated. Do not freeze.
We provide you with authentic, trustworthy and relevant information